lactobacillus salivarius Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now
Ligilactobacillus salivarius is a probiotic bacteria species that has been found to live in the gastrointestinal tract and exert a range of therapeutic properties including suppression of pathogenic bacteria.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

lactobacillus salivarium | lactobacillus salivarius bl 3123 | lactobacillus salivarius cect5713 | lactobacillus salivarius hn6 | lactobacillus salivarius ls159 | lactobacillus salivarius ps2 | lactobacillus salivarius ucc118 | lactobacillus salivarius w24

Organizations (30)

Research & Development (30)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (10)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (10)


 

Abortion, Induced (Phase 2)

Abortion, Spontaneous (Phase 2)

Colitis, Ulcerative (Phase 2/Phase 3)

Crohn Disease (Phase 2/Phase 3)

Dermatitis, Atopic (Phase 3)

Hypersensitivity (Phase 3)

Infections (Phase 1)

Infertility (Phase 2)

Mastitis (Phase 2/Phase 3)

Microbiota ()

Overview

  • Highest Phase: Phase 3
  • # of Trials: 30
  • # of Trial Organizations: 30

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue